BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24471909)

  • 61. BRAF V600E and Pten deletion in mice produces a histiocytic disorder with features of Langerhans cell histiocytosis.
    Nelson DS; Marano RL; Joo Y; Tian SY; Patel B; Kaplan DH; Shlomchik MJ; Stevenson K; Bronson RT; Rollins BJ
    PLoS One; 2019; 14(9):e0222400. PubMed ID: 31527903
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Status of Langerhans cell histiocytosis in children and adults].
    Kudo K
    Rinsho Ketsueki; 2019; 60(9):1308-1316. PubMed ID: 31597857
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Langerhans cell histiocytosis associated with classical Hodgkin lymphoma contains BRAF V600E mutation.
    Zhang S; Steinhilber J; Fend F
    Ann Hematol; 2019 Jan; 98(1):231-233. PubMed ID: 30003317
    [No Abstract]   [Full Text] [Related]  

  • 64. Clinicopathological features and BRAF
    Huo Z; Lu T; Liang Z; Ping F; Shen J; Lu J; Ma W; Zhao D; Zhong D
    Diagn Pathol; 2016 Oct; 11(1):100. PubMed ID: 27760550
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Langerhans cell histiocytosis: current advances in molecular pathogenesis.
    Sconocchia T; Foßelteder J; Sconocchia G; Reinisch A
    Front Immunol; 2023; 14():1275085. PubMed ID: 37965340
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adult-onset Langerhans cell histiocytosis of bone: A case series highlighting a rare entity.
    Javadi T; Hill C; McLemore ML; Oskouei S; Bahrami A
    Ann Diagn Pathol; 2023 Oct; 66():152171. PubMed ID: 37295039
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CSF1R Is Required for Differentiation and Migration of Langerhans Cells and Langerhans Cell Histiocytosis.
    Lonardi S; Scutera S; Licini S; Lorenzi L; Cesinaro AM; Gatta LB; Castagnoli C; Bollero D; Sparti R; Tomaselli M; Medicina D; Calzetti F; Cassatella MA; Facchetti F; Musso T; Vermi W
    Cancer Immunol Res; 2020 Jun; 8(6):829-841. PubMed ID: 32238382
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of BRAF-Inhibitor Therapy in BRAF
    Hazim AZ; Ruan GJ; Ravindran A; Abeykoon JP; Scheckel C; Vassallo R; Ryu JH; Tobin WO; Koster MJ; Bennani NN; Rech KL; Young JR; Shah MV; Goyal G; Go RS
    Oncologist; 2020 Dec; 25(12):1001-1004. PubMed ID: 32985015
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Squash smear cytology of Langerhans cell histiocytosis.
    Nahm JH; Yoon G; Do SI; Kim HS
    Int J Clin Exp Pathol; 2015; 8(7):7998-8007. PubMed ID: 26339366
    [TBL] [Abstract][Full Text] [Related]  

  • 70. BRAFE600-associated senescence-like cell cycle arrest of human naevi.
    Michaloglou C; Vredeveld LC; Soengas MS; Denoyelle C; Kuilman T; van der Horst CM; Majoor DM; Shay JW; Mooi WJ; Peeper DS
    Nature; 2005 Aug; 436(7051):720-4. PubMed ID: 16079850
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inflammatory serum cytokines and chemokines increase associated with the disease extent in pediatric Langerhans cell histiocytosis.
    Morimoto A; Oh Y; Nakamura S; Shioda Y; Hayase T; Imamura T; Kudo K; Imashuku S;
    Cytokine; 2017 Sep; 97():73-79. PubMed ID: 28582647
    [TBL] [Abstract][Full Text] [Related]  

  • 72. KRAS
    Kamata T; Giblett S; Pritchard C
    Blood; 2017 Jul; 130(4):514-526. PubMed ID: 28550040
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [BRAF V600E Mutation in Chinese Patients with Langerhans Cell Histiocytosis and Its Clinical Significance].
    Cheng XY; Li Y; Zhou J; Shu YG; Li XL; Fu B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):526-32. PubMed ID: 25948218
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations.
    Pina-Oviedo S; Medeiros LJ; Li S; Khoury JD; Patel KP; Alayed K; Cason RC; Bowman CJ; Yin CC
    Mod Pathol; 2017 May; 30(5):734-744. PubMed ID: 28084334
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Detection of clonal lymphoid receptor gene rearrangements in langerhans cell histiocytosis.
    Chen W; Wang J; Wang E; Lu Y; Lau SK; Weiss LM; Huang Q
    Am J Surg Pathol; 2010 Jul; 34(7):1049-57. PubMed ID: 20551822
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A circulating subset of BRAF
    Poch R; Le Louet S; Hélias-Rodzewicz Z; Hachem N; Plat G; Barkaoui MA; Lapillonne H; Delhommeau F; Emile JF; Donadieu J; Héritier S
    Br J Haematol; 2021 Aug; 194(4):745-749. PubMed ID: 34312844
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Bone and soft tissue Langerhans cell histiocytosis with multinucleated giant cells and BRAF V600E mutation].
    Machado I; Columbie A; Nieto Morales G; Forteza-Suarez M; Renó Céspedes JLS; Marhuenda Fluixa A; Llombart-Bosch A
    Rev Esp Patol; 2021; 54(2):136-140. PubMed ID: 33726891
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Senescence-Like Phenotypes in Human Nevi.
    Joselow A; Lynn D; Terzian T; Box NF
    Methods Mol Biol; 2017; 1534():175-184. PubMed ID: 27812879
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas.
    Routhier CA; Mochel MC; Lynch K; Dias-Santagata D; Louis DN; Hoang MP
    Hum Pathol; 2013 Nov; 44(11):2563-70. PubMed ID: 24071017
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevalence of the
    Stathi D; Yavropoulou MP; Allen CE; Abhyankar H; Scull B; Tsoli M; Andreakos E; Kaltsas G; Makras P
    Pediatr Hematol Oncol; 2022 Sep; 39(6):540-548. PubMed ID: 35139731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.